Department of Endocrinology, Dongfang Hospital, Beijing University of Chinese Medicine , Beijing, China.
School of Traditional Chinese Medicine, Capital Medical University , Beijing, China.
Bioengineered. 2020 Dec;11(1):841-851. doi: 10.1080/21655979.2020.1797282.
Tang-luo-ning (TLN) is a traditional Chinese herbal recipe that has been used to treat diabetic peripheral neuropathy (DPN); nevertheless, the underlying mechanism remains unclear. This study was aimed to investigate the microRNA (miRNA) expression profile in diabetic rats treated with TLN, and the target genes were predicted. Male Sprague-Dawley rats were randomly divided into control, diabetes, and TLN-treated diabetes groups. Diabetes was induced with streptozotocin, and TLN (5 g/kg/day) was orally given for eight weeks. Then, the sciatic nerves were harvested for miRNA microarray analyses. The differentially expressed miRNAs and their target genes were analyzed. Compared with the control rats, 24 miRNAs were significantly upregulated, and 59 were downregulated in the sciatic nerves of the diabetic rats by more than two folds (all < 0.05). In TLN-treated diabetes rats, 26 miRNAs were upregulated, and 14 were downregulated compared with diabetic rats without TLN treatment (all < 0.05). DPN-induced alterations of the miRNA profile were reversed by the TLN treatment. A total of 1402 target genes were screened. In GO analysis, genes in localization, cytoplasm, and protein binding processes were enriched, and the most significantly enriched pathways included the neurotrophin, Fc epsilon RI, and Wnt signaling pathways. Further analyses revealed that and genes were involved in these pathways. Our findings indicate that TLN may affect the Wnt and neurotrophin pathways by acting on and genes.
糖络宁是一种治疗糖尿病周围神经病变(DPN)的中药方剂,但作用机制尚不清楚。本研究旨在探讨糖络宁治疗糖尿病大鼠的miRNA 表达谱,预测其靶基因。雄性 Sprague-Dawley 大鼠随机分为对照组、糖尿病组和糖络宁治疗糖尿病组。糖尿病采用链脲佐菌素诱导,糖络宁(5g/kg/天)灌胃 8 周。然后采集坐骨神经进行 miRNA 微阵列分析。分析差异表达的 miRNA 及其靶基因。与对照组大鼠相比,糖尿病大鼠坐骨神经中 24 个 miRNA 显著上调,59 个 miRNA 下调超过 2 倍(均<0.05)。与未用糖络宁治疗的糖尿病大鼠相比,糖络宁治疗糖尿病大鼠中 26 个 miRNA 上调,14 个 miRNA 下调(均<0.05)。糖络宁治疗逆转了 DPN 诱导的 miRNA 谱改变。共筛选出 1402 个靶基因。GO 分析显示,定位、细胞质和蛋白结合过程中的基因富集,最显著富集的途径包括神经营养素、FcεRI 和 Wnt 信号通路。进一步分析表明,和基因参与这些途径。我们的研究结果表明,糖络宁可通过作用于和基因影响 Wnt 和神经营养素途径。